You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | -3,583.1% |
| ROCE | n/a |
| Latest | Forecast | |
|---|---|---|
| P/E | -0.5 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 57.6 | 41.0 |
| Price / Book value | 1.3 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 152.4% | -86.4% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 186.1% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | n/a | -23.99 | -26.08p | -12.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -28.44 | -36.17p | -2.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.21 | -29.43 | -36.75p | -2.7 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 0.53 | -30.35 | -22.80p | -5.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 0.52 | -57.47 | -31.83p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| 4D Pharma requests immediate suspension of its shares Sharecast News | 24 Jun |
|---|---|
| 4D Pharma reports progress in bladder cancer trial Sharecast News | 27 May |
| 4D Pharma gets FDA clearance for potential Parkinson's treatments Sharecast News | 22 Feb |
| Publication of Joint Administrators' Proposals | 04-Aug-22 15:35 |
|---|---|
| Temporary Pause of Recruitment in Clinical Trials | 01-Jul-22 17:35 |
| 4D Pharma receives Notice of Delisting from NASDAQ | 28-Jun-22 18:30 |
| Result of AGM | 28-Jun-22 15:18 |
| 4D Pharma | 27-Jun-22 17:31 |